Ditchcarbon
  • Contact
  1. Organizations
  2. Kedrion
Public Profile
Pharmaceutical Preparation Manufacturing
IT
updated a month ago

Kedrion Sustainability Profile

Company website

Kedrion Biopharma, commonly referred to as Kedrion, is a leading global player in the biopharmaceutical industry, headquartered in Italy. Founded in 2001, the company has established a strong presence in major operational regions, including Europe and North America, focusing on the development and production of human plasma-derived therapies. Kedrion's core offerings include immunoglobulins, clotting factors, and albumin, which are essential for treating various medical conditions. What sets Kedrion apart is its commitment to quality and innovation, ensuring that its products meet the highest safety standards. With a robust market position, Kedrion has achieved significant milestones, including expanding its product portfolio and enhancing its global distribution network, solidifying its reputation as a trusted provider in the biopharmaceutical sector.

DitchCarbon Score

How does Kedrion's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Kedrion's score of 22 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

21%

Let us know if this data was useful to you

Kedrion's reported carbon emissions

In 2023, Kedrion S.p.A. reported total carbon emissions of approximately 27,304,000 kg CO2e. This figure reflects a slight decrease from 2022, when emissions were about 30,122,000 kg CO2e. The emissions data for 2023 does not specify individual Scope 1, 2, or 3 emissions, as these values are not disclosed. However, in 2020, Kedrion reported a total of 6,600 kg CO2e, with Scope 1 emissions at approximately 6,573 kg CO2e and Scope 2 emissions at about 27 kg CO2e. Kedrion's emissions data is cascaded from its parent company, Kedrion Holding Spa, indicating a corporate family relationship. Despite the lack of specific reduction targets or initiatives outlined in their reports, the company is part of a broader industry context that increasingly prioritises sustainability and carbon footprint reduction. As of now, Kedrion has not established any formal science-based targets or specific climate pledges, which may limit their ability to demonstrate a structured approach to emissions reduction. The absence of documented reduction initiatives suggests that further commitment to climate action may be necessary for alignment with industry standards.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20162017201820192020202120222023
Scope 1
-
00,000,000
00,000,000
0,000,000
0,000
-
-
-
Scope 2
-
-
-
-
00
-
-
-
Scope 3
-
-
-
-
-
-
-
-

How Carbon Intensive is Kedrion's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Kedrion's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Kedrion's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Kedrion is in IT, which has a low grid carbon intensity relative to other regions.

Kedrion's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Kedrion has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Kedrion's Emissions with Industry Peers

Bio Products Laboratory Ltd.

GB
•
Pharmaceutical Preparation Manufacturing
Updated 27 days ago

Csl

AU
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

Catalent

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

ADMA Biologics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Maco Pharma International GmbH

DE
•
Health and social work services (85)
Updated about 1 month ago

HemaCare Corporation

US
•
Health and social work services (85)
Updated 3 months ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251204.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy